Early detection and diagnosis of many cancers is very challenging. Late stage detection of a
cancer always leads to high mortality rates. It is imperative to develop novel and more …

Poor aqueous solubility and poor bioavailability are major issues with many pharmaceutical
industries. By some estimation, 70–90% drug candidates in development stage while up-to …

Over the years, a plethora of materials–natural and synthetic–have been engineered at a
nanoscopic level and explored for drug delivery. Nanocarriers based on such materials …

The continuing increase of cancer morbidity and death rate requires efficient therapeutic
strategies. The traditional chemotherapy usually fails to treat cancer or prolong survival rate …

Nanomedicines for cancer treatment have been studied extensively over the last few
decades. Yet, only five anticancer nanomedicines have received approvals from the United …

Nanotechnology research over the past several decades has been aimed primarily at
improving the physicochemical properties of small molecules to produce druggable …

Abstract Development of ocular drug delivery system is one of the most technically
challenging tasks, when compared with other routes of drug delivery. Eye (an intricate …

Nanocrystals have exhibited great advantage for enhancing the dissolution rate of water
insoluble drugs due to the reduced size to nanoscale. However, current pharmaceutical …

Human skin is a multilayered physiochemical barrier protecting the human body. The
stratum corneum (SC) is the outermost keratinized layer of skin through which only …

Lipid polymer hybrid nanoparticles (LPHNPs) have been merged as potential nanocarriers
for treatment of cancer. In the present study, LPHNPs loaded with Sorafenib (SFN) were …